AtriCure
ATRC
99 hedge funds and large institutions have $560M invested in AtriCure in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 13 closing their positions.
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
3.17% more ownership
Funds ownership: 84.64% → 87.81% (+3.2%)
3% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 34
2% more capital invested
Capital invested by funds: $551M → $560M (+$9.81M)
1% less funds holding
Funds holding: 100 → 99 (-1)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $619K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$37.4M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$13.5M |
| 3 |
Neuberger Berman Group
New York
|
+$9.92M |
| 4 |
Millennium Management
New York
|
+$8.01M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$5.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
-$8.59M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$5.82M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$5.09M |
| 4 |
RCP
Rothschild Capital Partners
New York
|
-$4.7M |
| 5 |
CCI
Columbus Circle Investors
|
-$2.04M |
ATRC Hedge Fund Activity: Q1 2017 in Review
99 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2017, worth a combined $560M — up 1.8% from $551M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ATRC positions and 13 closed out — a net gain of 4 holders — while 35 added to existing stakes and 34 trimmed.
The largest buyer was BlackRock, adding an estimated $37.4M. The largest seller was William Blair Investment Management, exiting entirely with an estimated $8.59M sold.
- 99 institutional investors held AtriCure (ATRC) as of Q1 2017, down from 100 in Q4 2016.
- Funds reported $560M of AtriCure stock for Q1 2017, up 1.8% quarter-over-quarter.
- 17 funds opened new AtriCure positions in Q1 2017 and 13 closed out, a net change of +4 holders.
- The largest AtriCure buyer in Q1 2017 was BlackRock, an estimated $37.4M added.
- The largest AtriCure seller in Q1 2017 was William Blair Investment Management, an estimated $8.59M sold.
Based on aggregated 13F filings for Q1 2017.